ASKA Pharmaceutical Holdings Co (TSE:4886) COGS-to-Revenue : 0.51 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is ASKA Pharmaceutical Holdings Co COGS-to-Revenue?

ASKA Pharmaceutical Holdings Co's Cost of Goods Sold for the three months ended in Dec. 2023 was 円8,731 Mil. Its Revenue for the three months ended in Dec. 2023 was 円17,176 Mil.

ASKA Pharmaceutical Holdings Co's COGS to Revenue for the three months ended in Dec. 2023 was 0.51.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. ASKA Pharmaceutical Holdings Co's Gross Margin % for the three months ended in Dec. 2023 was 49.17%.

ASKA Pharmaceutical Holdings Co COGS-to-Revenue Historical Data

The historical data trend for ASKA Pharmaceutical Holdings Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASKA Pharmaceutical Holdings Co COGS-to-Revenue Chart

ASKA Pharmaceutical Holdings Co Annual Data

Trend

Mar22

Mar23

Mar24

COGS-to-Revenue

0.53

0.51

ASKA Pharmaceutical Holdings Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial							0.53	0.53	0.51	0.51	0.50

ASKA Pharmaceutical Holdings Co COGS-to-Revenue Calculation

ASKA Pharmaceutical Holdings Co's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	32179	/	62843
	=	0.51

ASKA Pharmaceutical Holdings Co's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	8731	/	17176
	=	0.51

ASKA Pharmaceutical Holdings Co (TSE:4886) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

ASKA Pharmaceutical Holdings Co's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	8731 / 17176
	=	49.17 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

ASKA Pharmaceutical Holdings Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of ASKA Pharmaceutical Holdings Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

ASKA Pharmaceutical Holdings Co (TSE:4886) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532

Website

https://www.aska-pharma-hd.co.jp

ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.

ASKA Pharmaceutical Holdings Co (TSE:4886) Headlines

No Headlines